Innate Pharma SA (IPHA, IPHYF)

CIK 1598599 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Innate Pharma SA.

Recent SEC filings

FiledFormAccession number
Sep 10, 20266-K0001628280-26-061214
Sep 2, 20266-K0001628280-26-059963
Aug 19, 20266-K0001628280-26-057935
Aug 14, 20266-K0001628280-26-056913
Aug 10, 20266-K0001628280-26-054966
Jul 23, 20266-K0001628280-26-049273
Jul 21, 20266-K0001598599-26-000008
Jun 22, 2026SCHEDULE 13G/A0000950103-26-009261
May 22, 20266-K0001628280-26-037515
May 19, 20266-K0001628280-26-036122
May 13, 20266-K0001628280-26-034383
May 12, 20266-K0001628280-26-033831
May 6, 20266-K0001628280-26-030874
Apr 23, 20266-K0001628280-26-026676
Apr 17, 20266-K0001628280-26-025688
Apr 13, 20266-K0001628280-26-024822
Apr 13, 20266-K0001628280-26-024819
Apr 10, 2026SCHEDULE 13G/A0000950103-26-005593
Apr 8, 20266-K0001628280-26-024144
Apr 3, 20266-K0001628280-26-023471
Apr 2, 20266-K0001628280-26-022913
Apr 1, 202620-F0001598599-26-000005
Mar 26, 20266-K0001628280-26-021168
Mar 19, 20266-K0001628280-26-019623
Mar 4, 2026SCHEDULE 13G/A0000950103-26-003227